New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq ・ Market Cap: Small
CEO Sales
Top Executive Recent Sales
Regular Sale Insiders
High Sales Frequency
High Trades Frequency
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 93 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 10 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 4,154,365 0 / 44,671 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $83,292,446 $0 / $895,618 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $6,515.6 - $22,877,262 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
4 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
59.75%
DIRECTORS
8.06%
OFFICERS
32.18%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.544 0.295 |
VALUE GINI INDEX Sector Average | 0.574 0.288 |
Enliven Therapeutics, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2025-01-10 2025-01-07 | Patel Anish | Officer | -$162,541 | 6,667 | $24.38 | -1.94% | 336,644 | -0.72% | +3.97% | |
2025-01-10 2025-01-07 | Patel Anish | Officer | -$528,612 | 21,700 | $24.36 | -6.06% | 336,644 | -0.72% | +3.97% | |
2025-01-07 2024-12-13 | Hohl Benjamin | Officer | -$25,040 | 1,000 | $25.04 | -7.14% | 13,000 | N/A | N/A | |
2024-12-31 2024-12-27 | Hohl Benjamin | Officer | -$94,903 | 4,250 | $22.33 | -100% | 0 | N/A | N/A | |
2024-12-02 2024-11-27 | Hohl Benjamin | Officer | -$131,670 | 5,250 | $25.08 | -100% | 0 | -3.36% | -0.04% | |
2024-10-30 2024-10-28 | Hohl Benjamin | Officer | -$180,000 | 6,250 | $28.8 | -100% | 0 | -1.90% | +2.15% | |
2024-10-22 2024-10-18 | Patel Anish | Officer | -$21,480 | 716 | $30 | -0.21% | 343,311 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Lyssikatos Joseph P | Officer | -$25,410 | 847 | $30 | -0.08% | 1,015,188 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Kintz Samuel | Director | -$27,720 | 924 | $30 | -0.09% | 1,002,892 | +0.41% | -2.04% | |
2024-10-22 2024-10-18 | Hohl Benjamin | Officer | -$24,420 | 814 | $30 | -100% | 0 | +0.41% | -2.04% |